CFPB fines Enova $15M, orders exec compensation tied to compliance
By 
Aaron Nicodemus2023-11-16T20:54:00
The Consumer Financial Protection Bureau (CFPB) levied a $15 million fine against nonbank online lender Enova International for “widespread illegal conduct” that violated a previous agency order.
The CFPB said in a press release Wednesday that Enova’s illegal conduct included “withdrawing funds from customers’ bank accounts without their permission, making deceptive statements about loans, and cancelling loan extensions.” The alleged actions affected more than 111,000 customers.
The CFPB fined the company $3.2 million in 2019 for similar alleged misconduct. The CFPB found new and continuing violations as it investigated whether Enova was complying with its previous order, the agency said.
Related articles
-
News BriefBankrupt retailer Express avoids fine in SEC understated CEO perks case
The Securities and Exchange Commission charged bankrupt fashion retailer Express with failing to disclose nearly $1 million in perks to a former chief executive, but did not levy a financial penalty thanks to its cooperation, the SEC said.
-
News BriefCFPB to require nonbanks to register outside enforcement orders
The Consumer Financial Protection Bureau passed a new rule requiring nonbank financial companies to register consumer protection orders filed against them by other federal agencies, courts, or states.
-
News BriefAtlantic Union Bank to pay $6.2M in CFPB overdraft case
Atlantic Union Bank agreed to pay $6.2 million as part of a settlement with the Consumer Financial Protection Bureau resolving allegations the bank illegally enrolled and misled customers in its checking account overdraft programs.
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”